From the Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Immunization Group, Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases.
Pediatr Infect Dis J. 2022 Nov 1;41(11):e461-e467. doi: 10.1097/INF.0000000000003641. Epub 2022 Jul 18.
This review provides updates on coronavirus disease 2019 (COVID-19) in children in Japan by summarizing published data. By the end of March 2022, Japan had experienced 6 waves of COVID-19 outbreaks. Over this time, the clinical features presented among children have changed in the context of the predominant variants. Although the COVID-19 pandemic affected children in terms of medical, physical and psychosocial aspects, the clinical outcomes have been favorable in Japan compared with those in some European countries and the United States, which may be partly due to a lower incidence of multisystem inflammatory syndromes in children and obesity. The COVID-19 vaccine has been available for children; however, the vaccination rate in children 5-11 years of age is lower than that in older children due to the government's lack of an active approach in this specific population. Further action is needed to improve the overall vaccination rates in children.
本综述通过总结已发表的数据,提供了日本儿童 2019 冠状病毒病(COVID-19)的最新情况。截至 2022 年 3 月底,日本已经历了 6 波 COVID-19 疫情爆发。在此期间,在主要变异株的背景下,儿童的临床表现发生了变化。尽管 COVID-19 大流行在医疗、身体和社会心理方面影响了儿童,但与一些欧洲国家和美国相比,日本的临床结局较为有利,这可能部分归因于儿童中多系统炎症综合征和肥胖的发病率较低。COVID-19 疫苗已可用于儿童;然而,由于政府在这一特定人群中缺乏积极措施,5-11 岁儿童的疫苗接种率低于年龄较大的儿童。需要采取进一步行动来提高儿童的总体疫苗接种率。